SI-BONE, Inc. (SIBN)

From the record

SI-BONE, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

SI-BONE, Inc.'s 7 filed years say what it did: revenue went from $67 million in fiscal 2019 to $201 million in fiscal 2025, up 20% a year; it rose in 6 of 6 years; it never fell from a peak; net income was positive in 0 of 7 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, SI-BONE, Inc. lost about 11 cents for every dollar of shareholders' money, and gross profitability: its products earned about 67 cents per dollar of everything the company owns. Leverage: it owed about 26 cents per dollar of assets, and net share issuance: its share count grew 3.6% over the year (the filed statements).

From the record

SI-BONE, Inc.'s standing among 109 graded names in its industry family: revenue of $201 million in fiscal 2025 ranks in the top 39% by size; a net margin of -9.4% ranks in the top 38%; revenue growth of 23.6% a year over the last 3 filed years ranks in the top 31% (its annual reports).

From the record

SI-BONE, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Francis, Laura (Chief Executive Officer, as filed), filing under that title since 2021-08-16, 5.2 years (top 48% of its family); the 11 officers and directors filing in the last fifteen months have been on the record a median of 8.1 years (top 18%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 11 people in charge now (top 30%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

SI-BONE, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $42 million against debt of $36 million leaves 2.8% of its assets as net cash, bottom 36% of its family; cash from operations less capital spending is -4.5% of revenue (top 49%); a gross margin of 79.6% (top 14%); research spending of 8.7% of revenue (bottom 38%) (its annual report).

From the record

SI-BONE, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 23.6% a year over the last three filed years against 20% over all 7, speeding up (top 21% of its family); the newest year grew 20.2% (top 31%); research spending grew 8.6% a year (top 41%); capital spending grew -4% a year (bottom 47%) (its annual reports). SI-BONE, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

SI-BONE, Inc.'s newest year against its own record: revenue of $201 million in fiscal 2025 came in 4.1% below the $210 million its prior three years' pace pointed to (bottom 46% of its family); net income of $19 million against a prior three-year average of $45 million (top 31%); a net margin of -9.4% against -35.8% before (top 31%) (its annual reports).